Ethypharm to borrow €285m for DB Ashbourne acquisition
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
LevFinLevFin Leveraged Loans

Ethypharm to borrow €285m for DB Ashbourne acquisition

Max Bower
October 26, 2015 12:30 PM
cegedim12.jpg

Ethypharm, the French pharmaceutical company, is holding a bank meeting today (October 26) for €285.5m of new debt to finance the acquisition of DB Ashbourne, the UK branded drugs firm.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansNews contentLoans and High YieldLevFinLeveraged LoansLevFin Leveraged Loans
MB
Max Bower
Gift this article